Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise

Complicated pregnancies are nowadays a major public health concern, with possible lethality or sequelae both for the mother and the fetus. Blood coagulation disorders (including antiphospholipid syndrome, factor V Leiden mutation and antithrombin deficiency) and hypertensive gestational disorders ar...

Full description

Bibliographic Details
Main Authors: Camélia Oualiken, Olivia Martz, Nadia Idrissi, Fara Tanjona Harizay, Laurent Martin, Emmanuel De Maistre, Lou Ricaud, Georges Tarris
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1083806/full
_version_ 1797961773759856640
author Camélia Oualiken
Camélia Oualiken
Olivia Martz
Nadia Idrissi
Fara Tanjona Harizay
Laurent Martin
Emmanuel De Maistre
Lou Ricaud
Georges Tarris
author_facet Camélia Oualiken
Camélia Oualiken
Olivia Martz
Nadia Idrissi
Fara Tanjona Harizay
Laurent Martin
Emmanuel De Maistre
Lou Ricaud
Georges Tarris
author_sort Camélia Oualiken
collection DOAJ
description Complicated pregnancies are nowadays a major public health concern, with possible lethality or sequelae both for the mother and the fetus. Blood coagulation disorders (including antiphospholipid syndrome, factor V Leiden mutation and antithrombin deficiency) and hypertensive gestational disorders are very well-known contributors of complicated pregnancies with poor fetal outcome, such as intrauterine growth retardation (IUGR) and fetal demise. Less commonly, vascular malformations of the placenta can also potentially lead to serious complications such as IUGR and fetal death. These malformations include hypercoiled umbilical cord, umbilical cord knot, umbilical cord varix, umbilical cord arterial or venous aneurysm, and velamentous insertion of the umbilical cord potentially leading to Benckiser's hemorrhage. Here, we report the case of a 29-year-old Gravida 2 Para 0 mother with previous history of stillbirth and smoking, admitted to the obstetrics department for the absence of fetal movement at 38 weeks of amenorrhea (WA). First-trimester and second-trimester routine ultrasounds were otherwise normal. Ultrasound performed at 38 WA revealed a 83 × 66 × 54 mm cystic heterogenous mass at the umbilical cord insertion. After delivery, fetal and placental pathology as well as maternal blood testing were performed. Fetal pathology was otherwise normal, except for diffuse congestion and meconial overload suggesting acute fetal distress. Fetal karyotype was normal (46 XX). Placental pathology revealed an umbilical artery aneurysm (UAA) at the base of the insertion of the umbilical cord, lined with a CD34+ CD31+ endothelium. After dissection, the aneurysm was filled with hemorrhagic debris, indicating aneurysm thrombosis. Histopathology revealed associated maternal vascular malperfusion (MVM) and increased peri-villous fibrin (IPF). Maternal blood tests revealed heterozygous factor V Leiden mutation, without other associated auto-immune conditions (such as antiphospholipid syndrome). Umbilical artery aneurysms remain extremely rare findings in the placenta, with <20 reported cases. Umbilical artery aneurysms have tendency to be located at the base of the insertion of the placenta, and lead to fetal demise in more than 60% of cases, mainly due to aneurysmal thrombosis, hematoma, possible vascular compression and/or rupture. Umbilical vessel aneurysms can be associated with trisomy 18 or 13. In our case, the association of factor V Leiden mutation, a hypercoagulable state, with UAA could explain massive thrombosis of the aneurysmal lumen and sudden fetal demise. Further consideration of current guidelines for surveillance and management of UAA would allow appropriate planned delivery in maternal care settings.
first_indexed 2024-04-11T01:02:58Z
format Article
id doaj.art-4d9437f8a9564b50a4e0c486489d8d70
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-11T01:02:58Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-4d9437f8a9564b50a4e0c486489d8d702023-01-04T14:27:34ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-01-01910.3389/fmed.2022.10838061083806Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demiseCamélia Oualiken0Camélia Oualiken1Olivia Martz2Nadia Idrissi3Fara Tanjona Harizay4Laurent Martin5Emmanuel De Maistre6Lou Ricaud7Georges Tarris8Department of Pathology, University Hospital of Dijon, Dijon, FranceForensics Institute, University Hospital of Dijon, Dijon, FranceDepartment of Obstetrics and Gynecology, Prenatal Diagnostic Center, Gynecology Emergency Services, University Hospital of Dijon, Dijon, FrancePrivate Practice Center, Dijon, FranceDepartment of Pathology, University Hospital of Dijon, Dijon, FranceDepartment of Pathology, University Hospital of Dijon, Dijon, FranceDepartment of Hemostasis, University Hospital of Dijon, Dijon, FranceDepartment of Obstetrics and Gynecology, Prenatal Diagnostic Center, Gynecology Emergency Services, University Hospital of Dijon, Dijon, FranceDepartment of Pathology, University Hospital of Dijon, Dijon, FranceComplicated pregnancies are nowadays a major public health concern, with possible lethality or sequelae both for the mother and the fetus. Blood coagulation disorders (including antiphospholipid syndrome, factor V Leiden mutation and antithrombin deficiency) and hypertensive gestational disorders are very well-known contributors of complicated pregnancies with poor fetal outcome, such as intrauterine growth retardation (IUGR) and fetal demise. Less commonly, vascular malformations of the placenta can also potentially lead to serious complications such as IUGR and fetal death. These malformations include hypercoiled umbilical cord, umbilical cord knot, umbilical cord varix, umbilical cord arterial or venous aneurysm, and velamentous insertion of the umbilical cord potentially leading to Benckiser's hemorrhage. Here, we report the case of a 29-year-old Gravida 2 Para 0 mother with previous history of stillbirth and smoking, admitted to the obstetrics department for the absence of fetal movement at 38 weeks of amenorrhea (WA). First-trimester and second-trimester routine ultrasounds were otherwise normal. Ultrasound performed at 38 WA revealed a 83 × 66 × 54 mm cystic heterogenous mass at the umbilical cord insertion. After delivery, fetal and placental pathology as well as maternal blood testing were performed. Fetal pathology was otherwise normal, except for diffuse congestion and meconial overload suggesting acute fetal distress. Fetal karyotype was normal (46 XX). Placental pathology revealed an umbilical artery aneurysm (UAA) at the base of the insertion of the umbilical cord, lined with a CD34+ CD31+ endothelium. After dissection, the aneurysm was filled with hemorrhagic debris, indicating aneurysm thrombosis. Histopathology revealed associated maternal vascular malperfusion (MVM) and increased peri-villous fibrin (IPF). Maternal blood tests revealed heterozygous factor V Leiden mutation, without other associated auto-immune conditions (such as antiphospholipid syndrome). Umbilical artery aneurysms remain extremely rare findings in the placenta, with <20 reported cases. Umbilical artery aneurysms have tendency to be located at the base of the insertion of the placenta, and lead to fetal demise in more than 60% of cases, mainly due to aneurysmal thrombosis, hematoma, possible vascular compression and/or rupture. Umbilical vessel aneurysms can be associated with trisomy 18 or 13. In our case, the association of factor V Leiden mutation, a hypercoagulable state, with UAA could explain massive thrombosis of the aneurysmal lumen and sudden fetal demise. Further consideration of current guidelines for surveillance and management of UAA would allow appropriate planned delivery in maternal care settings.https://www.frontiersin.org/articles/10.3389/fmed.2022.1083806/fullumbilical vessel aneurysmthrombosisthrombophiliafetal demisestillbirthumbilical artery aneurysm
spellingShingle Camélia Oualiken
Camélia Oualiken
Olivia Martz
Nadia Idrissi
Fara Tanjona Harizay
Laurent Martin
Emmanuel De Maistre
Lou Ricaud
Georges Tarris
Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise
Frontiers in Medicine
umbilical vessel aneurysm
thrombosis
thrombophilia
fetal demise
stillbirth
umbilical artery aneurysm
title Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise
title_full Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise
title_fullStr Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise
title_full_unstemmed Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise
title_short Case report: Umbilical vessel aneurysm thrombosis and factor V Leiden mutation leading to fetal demise
title_sort case report umbilical vessel aneurysm thrombosis and factor v leiden mutation leading to fetal demise
topic umbilical vessel aneurysm
thrombosis
thrombophilia
fetal demise
stillbirth
umbilical artery aneurysm
url https://www.frontiersin.org/articles/10.3389/fmed.2022.1083806/full
work_keys_str_mv AT cameliaoualiken casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT cameliaoualiken casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT oliviamartz casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT nadiaidrissi casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT faratanjonaharizay casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT laurentmartin casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT emmanueldemaistre casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT louricaud casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise
AT georgestarris casereportumbilicalvesselaneurysmthrombosisandfactorvleidenmutationleadingtofetaldemise